Stephanie Link, Chief investment strategist, HightowerUnitedHealth Group IncUNHBUYNov 20, 2026
She added to it; shares are on sale on the Care Advantage court ruling. UNH is number in the sector with the best balance sheet and CEO who owns a lot of shares. Last month, UNH announced a $50 billion share buyback. Their medical loss ratio is improving as are their fundamentals.
It was a great growth story for years until restructuring. Gives great exposure to U.S. hospitals. Buy closet to $300, and sell at $450-500. It could go sideways for years.
Costs are still running high. He still owns as part of a diversified healthcare allocation, but he's neutral on whether it's the best place for new $$. Over time, will probably give you 10-11% per year (decent compounding, but not a top pick idea).
(Note the short timeframe.) Still likes it at these prices. Regaining earnings power after several setbacks, can still approach $500 as it regains confidence of investors.
Hits April 2025 highs. Fundamentals have been improving since last quarter. Healthcare is defensive, attractive now. Is happy to hold on. Has been great for him.
It relies on US federal and state funding through Medicare for a lot of its revenue. Too risky. The glory days of growing through this kind of funding are done.
A battleground stock. Has done pretty well since the revision in the Medicaid rate from 0 to 3%, a major change. Run by a great CEO. Is not overvalued now.
She added to it; shares are on sale on the Care Advantage court ruling. UNH is number in the sector with the best balance sheet and CEO who owns a lot of shares. Last month, UNH announced a $50 billion share buyback. Their medical loss ratio is improving as are their fundamentals.